Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia.

@article{Schaik2013AdenomasIP,
  title={Adenomas in patients with inflammatory bowel disease are associated with an increased risk of advanced neoplasia.},
  author={Fiona D. M. van Schaik and Erik Mooiweer and Mike van der Have and Tim D. G. Belderbos and Fiebo J. W. ten Kate and George Johan Arnold Offerhaus and Marguerite E. I. Schipper and Gerard Dijkstra and Marieke J. Pierik and Pieter C. F. Stokkers and Cyriel Y. Ponsioen and Dirk J de Jong and Daniel W. Hommes and A A van Bodegraven and Peter D. Siersema and Martijn G. H. van Oijen and Bas Oldenburg},
  journal={Inflammatory bowel diseases},
  year={2013},
  volume={19 2},
  pages={
          342-9
        }
}
BACKGROUND It is still unclear whether inflammatory bowel disease (IBD) patients with adenomas have a higher risk of developing high-grade dysplasia (HGD) or colorectal cancer (CRC) than non-IBD patients with sporadic adenomas. We compared the risk of advanced neoplasia (AN, defined as HGD or CRC) in IBD patients with adenomas to IBD patients without adenomas and patients without IBD with adenomas. METHODS IBD patients with a histological adenoma diagnosis (IBD + adenoma), age-matched IBD… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 2 times over the past 90 days. VIEW TWEETS